Tradename: ADACEL
Proper Name: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed
Indication: To include immunization during the third trimester of pregnancy to prevent pertussis in infants younger than 2 months of age.
Adacel is a vaccine indicated for:
Active booster immunization against tetanus, diphtheria and pertussis. Adacel is approved for use in persons 10 through 64 years of age.
Immunization during the third trimester of pregnancy to prevent pertussis in infants younger than 2 months of age.
Approval Date: 01/09/2023
Manufacturer: Sanofi Pasteur Limited
More: https://www.fda.gov/vaccines-blood-biologics/vaccines/adacel